VTR(SZ:300381) Xin Lang Zheng Quan·2025-10-20 03:24Core Viewpoint - Yidoli's stock price has shown a slight increase recently, but the overall performance this year has been negative, indicating potential challenges in the market [1][2]. Company Overview - Yidoli Biotechnology Co., Ltd. is located in Zhuhai, Guangdong Province, established on September 3, 1991, and listed on January 28, 2014. The company specializes in the research, production, sales, and service of biological enzyme preparations, steroid hormone raw materials, plant extracts, and animal nutrition and health products, providing comprehensive biotechnology solutions to customers [2]. - The main revenue composition of Yidoli includes: biological enzyme preparations (83.94%), plant extracts (8.34%), feed and feed additives (6.78%), and other products (0.95%) [2]. Financial Performance - As of September 30, Yidoli's total market capitalization is 3.344 billion yuan, with a recent stock price of 6.81 yuan per share [1]. - For the first half of 2025, Yidoli achieved operating revenue of 415 million yuan, a year-on-year increase of 4.48%, while the net profit attributable to shareholders decreased by 66.50% to 13.997 million yuan [2]. - Since its A-share listing, Yidoli has distributed a total of 359 million yuan in dividends, with 125 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, Yidoli has 20,100 shareholders, with an average of 24,399 circulating shares per person, showing no change from the previous period [2]. - Among the top ten circulating shareholders, the Guotai Zhongzheng Livestock Breeding ETF ranks as the sixth largest, holding 5.576 million shares, an increase of 850,600 shares compared to the previous period [3].